[HTML][HTML] An integrated virtual pathology education platform developed using Microsoft Power Apps and Microsoft Teams

A Rajaram, C Olory, V Leduc, G Evaristo, K Coté… - Journal of Pathology …, 2022 - Elsevier
The transition towards digital pathology and an extensive selection of video conferencing
platforms have helped provide continuity to education even during the COVID-19 pandemic. …

Phase II trial of perioperative chemotherapy+ avelumab in locally advanced gastroesophageal adenocarcinoma: Preliminary results.

…, J Cools-Lartigue, M Hickeson, G Artho, G Evaristo… - 2021 - ascopubs.org
4046 Background: Perioperative chemotherapy improves cure rate in locally advanced
gastroesophageal adenocarcinoma (GEA), and immune checkpoint inhibitors are active at the …

[HTML][HTML] Relation between mismatch repair status, chemoresponse, survival and anatomic location in gastroesophageal adenocarcinoma

G Evaristo, A Katz, JL Ramírez-GarcíaLuna… - Canadian Journal of …, 2023 - ncbi.nlm.nih.gov
Background: It has recently been reported that mismatch repair (MMR) status and
microsatellite instability (MSI) status in gastroesophageal carcinomas predict surgical, …

Portosinusoidal Vascular Disorder: A Heretofore Unrecognized Manifestation of Sickle Cell Disease?

P Jafari, G Evaristo, XA Du, AE Sharma, V Marcus… - Modern Pathology, 2024 - Elsevier
Portosinusoidal vascular disorder (PSVD) is a recently proposed histopathologic entity that
encompasses a spectrum of often subtle hepatic microvascular lesions and related …

[HTML][HTML] Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based …

G Marcq, G Evaristo, R Kool, S Shinde-Jadhav… - European Urology Open …, 2022 - Elsevier
Background No biomarkers are recommended for patients undergoing radiation-based
therapy (RT) for muscle-invasive bladder cancer (MIBC). Objective We aim to evaluate the …

Crohn's Disease Features in Anastomotic Biopsies from Patients With and Without Crohn's Disease: Diagnostic and Prognostic Value

G Evaristo, J Szczepanski, MS Farag, DT Rubin… - Modern Pathology, 2023 - Elsevier
Endoscopic evidence of disease activity is a critical predictor of clinical relapse in patients
with Crohn’s disease (CD), and histologic disease activity is evolving as a similarly important …

Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma

G Evaristo, PO Fiset, S Camilleri-Broët… - The American Journal …, 2020 - journals.lww.com
1. Haller F, Skálová A, Ihrler S, et al. Nuclear NR4A3 immunostaining is a specific and sensitive
novel marker for acinic cell carcinoma of the salivary glands. Am J Surg Pathol. 2019; 43: …

Perioperative immunochemotherapy (mDCF+ avelumab) in locally advanced gastro-esophageal adenocarcinoma: A phase II trial.

…, V Marcus, S Camilleri-Broët, A Spatz, G Evaristo… - 2023 - ascopubs.org
4055 Background: Perioperative chemotherapy improves cure rate in locally advanced
gastro-esophageal adenocarcinoma (GEA). Immune checkpoint inhibitors have activity in GEA. …

MP41-14 IMPACT OF PD-L1 EXPRESSION IN THE TUMOR MICROENVIRONMENT ON ONCOLOGICAL OUTCOMES FOR PATIENTS TREATED WITH …

G Marcq, G Evaristo, R Kool… - The Journal of …, 2021 - auajournals.org
INTRODUCTION AND OBJECTIVE: We aim to evaluate the role of PD-L1 expression in the
tumor microenvironment on oncological outcomes for patients treated with trimodality therapy …

Morphologic alterations post trimodal therapy in muscle-invasive urothelial carcinoma: understanding the impact of post-treatment changes on the pathological …

G Evaristo, B Khadang, R Kool, G Marcq, MS Farag… - Human Pathology, 2022 - Elsevier
While surveillance biopsies play a critical role in management of patients with muscle
invasive bladder cancer (MIBC) treated with trimodal therapy (TMT), their assessment is often …